Correspondence 0001193125-24-261709 from Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc.
Date: Nov. 19, 2024 · CIK: 0000882361 · Accession: 0001193125-24-261709
AI Filing Summary & Sentiment
File numbers found in text: 333-281201
Letter
Aptose Biosciences, Inc.
66 Wellington Street West, Suite 5300
TD Bank Tower Box 48
Toronto, Ontario, Canada
November 19, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C.
Attention: Jimmy McNamara
Re: Aptose Biosciences Inc. – Registration Statement on Form S-1 (File No. 333-281201)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-281201), as amended (the “Registration Statement”), of Aptose Biosciences Inc. We respectfully request that the Registration Statement become effective as of 5:00 p.m., Eastern Time, on November 20, 2024, or as soon thereafter as is reasonably practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Dan Miller at (604) 630-5199.
Very truly yours,
Aptose Biosciences Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Aptose Biosciences, Inc. 66 Wellington Street West, Suite 5300 TD Bank Tower Box 48 Toronto, Ontario, Canada November 19, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara Re: Aptose Biosciences Inc. – Registration Statement on Form S-1 (File No. 333-281201) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-281201), as amended (the “Registration Statement”), of Aptose Biosciences Inc. We respectfully request that the Registration Statement become effective as of 5:00 p.m., Eastern Time, on November 20, 2024, or as soon thereafter as is reasonably practicable. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Dorsey & Whitney LLP, by calling Dan Miller at (604) 630-5199. Very truly yours, Aptose Biosciences Inc. By: /s/ William G. Rice Name: William G. Rice Title: Chief Executive Officer